• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

更改尿崩症名称：尿崩症更名工作组的立场声明。

Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus.

机构信息

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.

Department of Pediatric Endocrinology, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.

出版信息

J Clin Endocrinol Metab. 2022 Dec 17;108(1):1-3. doi: 10.1210/clinem/dgac547.

DOI:10.1210/clinem/dgac547
PMID:36355385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9759163/
Abstract

Recent data show that patients with a diagnosis of diabetes insipidus (DI) are coming to harm. Here we give the rationale for a name change to arginine vasopressin deficiency and resistance for central and nephrogenic DI, respectively.

摘要

最近的数据表明，患有尿崩症（DI）诊断的患者正在受到伤害。在这里，我们分别为中枢性和肾源性 DI 的精氨酸加压素缺乏和抵抗改名为提供了理由。

相似文献

1
Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus.更改尿崩症名称：尿崩症更名工作组的立场声明。
J Clin Endocrinol Metab. 2022 Dec 17;108(1):1-3. doi: 10.1210/clinem/dgac547.
2
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.更改尿崩症名称：尿崩症更名工作组的立场声明。
Eur J Endocrinol. 2022 Oct 14;187(5):P1-P3. doi: 10.1530/EJE-22-0751. Print 2022 Nov 1.
3
Gestational diabetes insipidus: Diagnosis and management.妊娠糖尿病性尿崩症：诊断与管理。
Best Pract Res Clin Endocrinol Metab. 2020 Sep;34(5):101384. doi: 10.1016/j.beem.2020.101384. Epub 2020 Feb 27.
4
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.更改尿崩症名称：尿崩症更名工作组的立场声明。
Endocr J. 2022 Nov 28;69(11):1281-1284. doi: 10.1507/endocrj.EJ20220831. Epub 2022 Oct 14.
5
Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus.更改尿崩症名称：考虑更改尿崩症名称的工作组的立场声明。
Arch Endocrinol Metab. 2022 Nov 17;66(6):868-870. doi: 10.20945/2359-3997000000528. Epub 2022 Oct 11.
6
New developments and concepts in the diagnosis and management of diabetes insipidus (AVP-deficiency and resistance).尿崩症（抗利尿激素缺乏和抵抗）诊断与管理的新进展和概念
J Neuroendocrinol. 2023 Jan;35(1):e13233. doi: 10.1111/jne.13233. Epub 2023 Jan 22.
7
Diabetes insipidus: diagnosis and treatment of a complex disease.尿崩症：一种复杂疾病的诊断与治疗
Cleve Clin J Med. 2006 Jan;73(1):65-71. doi: 10.3949/ccjm.73.1.65.
8
Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency.精氨酸血管加压素缺乏症：诊断、治疗以及催产素缺乏的相关性。
Nat Rev Endocrinol. 2024 Aug;20(8):487-500. doi: 10.1038/s41574-024-00985-x. Epub 2024 May 1.
9
Genetics of Diabetes Insipidus.尿崩症的遗传学。
Endocrinol Metab Clin North Am. 2017 Jun;46(2):305-334. doi: 10.1016/j.ecl.2017.01.002. Epub 2017 Feb 28.
10
Diagnosis and Management of Central Diabetes Insipidus in Adults.成人中枢性尿崩症的诊断与治疗。
J Clin Endocrinol Metab. 2022 Sep 28;107(10):2701-2715. doi: 10.1210/clinem/dgac381.

引用本文的文献

1
Idiopathic Arginine Vasopressin Deficiency With an Incidental Non-functional Pituitary Microadenoma in an Elderly Diabetic Woman.一名老年糖尿病女性患特发性精氨酸加压素缺乏症并伴有偶然发现的无功能垂体微腺瘤
Cureus. 2025 Aug 13;17(8):e89995. doi: 10.7759/cureus.89995. eCollection 2025 Aug.
2
Nephrogenic Diabetes Insipidus: Three Decades of Clinical Reality.肾性尿崩症：三十年临床实况
Cureus. 2025 Aug 8;17(8):e89635. doi: 10.7759/cureus.89635. eCollection 2025 Aug.
3
A Novel Pathogenic Variant of the Gene Leading to Arginine Vasopressin Resistance Since the Neonatal Period.一种自新生儿期起导致抗精氨酸加压素的该基因的新型致病变异。
Genes (Basel). 2025 Aug 21;16(8):989. doi: 10.3390/genes16080989.
4
'Un-thirsty' hypernatremia.“无口渴感”的高钠血症
Endocrinol Diabetes Metab Case Rep. 2025 Jul 24;2025(3). doi: 10.1530/EDM-25-0008. Print 2025 Jul 1.
5
The changing landscape in the evaluation of hypotonic polyuria in children and adolescents: the role of the new copeptin stimulation tests.儿童和青少年低渗性多尿评估的变化态势：新型 copeptin 刺激试验的作用
J Pediatr Endocrinol Metab. 2025 May 23. doi: 10.1515/jpem-2025-0046.
6
A Pedigree Study of Hereditary Diabetes Insipidus Caused by X Chromosome AVPR2 Gene Mutation.一项关于由X染色体AVPR2基因突变引起的遗传性尿崩症的家系研究。
Int Med Case Rep J. 2025 May 2;18:529-538. doi: 10.2147/IMCRJ.S514461. eCollection 2025.
7
Prognostic Implications of Diabetes Insipidus in Heart Failure Hospitalizations: Insights from the U.S. National Readmissions Database 2016-2021.尿崩症在心力衰竭住院治疗中的预后意义：来自2016 - 2021年美国国家再入院数据库的见解
J Clin Med. 2025 Mar 28;14(7):2308. doi: 10.3390/jcm14072308.
8
Hashimoto's thyroiditis- What's in a name?桥本甲状腺炎——名字里有什么含义？
Hormones (Athens). 2025 Apr 2. doi: 10.1007/s42000-025-00646-2.
9
Sex-dependent increases in oxytocin levels in response to intravenous kisspeptin in humans.人类静脉注射 kisspeptin 后，催产素水平的性别依赖性升高。
Eur J Endocrinol. 2025 Mar 3;192(3):K24-K29. doi: 10.1093/ejendo/lvaf001.
10
Desmopressin prescription safety in adult inpatients: a real-world tertiary centre experience.去氨加压素在成年住院患者中的处方安全性：一家三级中心的真实世界经验
Endocr Connect. 2025 Feb 11;14(3). doi: 10.1530/EC-24-0441. Print 2025 Mar 1.

本文引用的文献

1
Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey.从患者角度看中枢性尿崩症：管理、心理共病和疾病更名：国际网络调查结果。
Lancet Diabetes Endocrinol. 2022 Oct;10(10):700-709. doi: 10.1016/S2213-8587(22)00219-4. Epub 2022 Aug 22.
2
Time for change: Renaming Diabetes Insipidus to improve patient safety.变革时刻：重新命名尿崩症以提高患者安全。
Clin Endocrinol (Oxf). 2018 May;88(5):625-626. doi: 10.1111/cen.13578. Epub 2018 Mar 22.
3
All medical eponyms should be abandoned.所有医学上的人名（或地名）命名法都应被摒弃。
Presse Med. 2008 Feb;37(2 Pt 1):250-1. doi: 10.1016/j.lpm.2007.11.005. Epub 2007 Dec 27.
4
Wegener's granulomatosis.韦格纳肉芽肿病
Lancet. 2006 Apr 22;367(9519):1362-6. doi: 10.1016/S0140-6736(06)68583-8.
5
Declining use of the eponym "Reiter's syndrome" in the medical literature, 1998-2003.1998 - 2003年医学文献中“赖特综合征”这一命名使用频率的下降
J Am Acad Dermatol. 2005 Oct;53(4):720-3. doi: 10.1016/j.jaad.2005.06.048.
6
Diabetes insipidus: historical aspects.尿崩症：历史回顾
Pituitary. 2004;7(1):33-8. doi: 10.1023/b:pitu.0000044633.52516.e1.
7
Notes on the history of eponymic idiopathic vasculitis: the diseases of Henoch and Schönlein, Wegener, Churg and Strauss, Horton, Takayasu, Behçet, and Kawasaki.以人名命名的特发性血管炎的历史笔记：亨诺赫和许兰氏病、韦格纳氏病、丘格和施特劳斯病、霍顿氏病、高安氏病、白塞氏病和川崎病。
Arthritis Care Res. 2000 Aug;13(4):237-45. doi: 10.1002/1529-0131(200008)13:4<237::aid-anr8>3.0.co;2-j.
8
Thirst and vasopressin function in normal and disordered states of water balance.口渴与血管加压素在水平衡正常及紊乱状态下的作用。
J Lab Clin Med. 1983 Mar;101(3):351-71.
9
The Greek concept of diabetes.希腊人对糖尿病的概念。
Bull N Y Acad Med. 1972 Sep;48(8):1033-6.
10
The amenorrhoea-galactorrhea syndrome: present diagnostic and therapeutic perspectives.闭经-溢乳综合征：当前的诊断与治疗观点
Acta Eur Fertil. 1975 Dec;6(4):331-8.